Tango Therapeutics had a revenue of 3.18M in the quarter ending Jun 30, 2025, with -41.01%. This bring the company's revenue in the last twelve months to 24.30M, Increased -40.73%. In the fiscal year ending Dec 31, 2024, Tango Therapeutics had annual revenue of 42.07M with 15.17% growth.